News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,080 Results
Type
Article (2431)
Company Profile (39)
Press Release (35610)
Section
Business (14113)
Career Advice (77)
Deals (2076)
Drug Delivery (8)
Drug Development (4099)
Employer Resources (10)
FDA (431)
Job Trends (761)
News (20127)
Policy (1052)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (143)
Allergies (4)
Alliances (3469)
ALS (4)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (432)
Artificial intelligence (9)
Autoimmune disease (2)
Automation (1)
Bankruptcy (11)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (17)
Cancer (132)
Cardiovascular disease (4)
Career advice (64)
Career pathing (1)
CAR-T (14)
Cell therapy (42)
Cervical cancer (2)
Clinical research (3170)
Collaboration (89)
Compensation (44)
COVID-19 (180)
CRISPR (7)
C-suite (26)
Cystic fibrosis (2)
Data (104)
Denatured (3)
Depression (3)
Diabetes (9)
Diagnostics (464)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4229)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6003)
Executive appointments (88)
FDA (474)
Featured Employer (3)
Funding (74)
Gene editing (14)
Gene therapy (17)
GLP-1 (60)
Government (149)
Healthcare (704)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (15)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (987)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (3)
Layoffs (36)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (18)
MASH (4)
Medical device (306)
Medtech (306)
Mergers & acquisitions (1151)
Metabolic disorders (32)
Multiple sclerosis (6)
Neurodegenerative disease (8)
Neuropsychiatric disorders (3)
Neuroscience (88)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (334)
Now hiring (4)
Obesity (15)
Opinion (15)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (19)
Patient recruitment (3)
Peanut (1)
People (5633)
Pharmaceutical (5)
Phase I (1371)
Phase II (1588)
Phase III (844)
Pipeline (71)
Podcasts (4)
Policy (12)
Postmarket research (30)
Preclinical (588)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (21)
Real estate (419)
Recruiting (5)
Regulatory (802)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (24)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (338)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (488)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1639)
Vaccines (28)
Venture capitalists (7)
Webinars (2)
Weight loss (11)
Women's health (1)
Worklife (1)
Date
Today (9)
Last 7 days (63)
Last 30 days (227)
Last 365 days (2561)
2025 (641)
2024 (2610)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1860)
Australia (298)
California (775)
Canada (130)
China (38)
Colorado (19)
Connecticut (10)
Delaware (3)
Europe (3805)
Florida (43)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (31)
Japan (7)
Kansas (12)
Maryland (24)
Massachusetts (286)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (2)
New Hampshire (2)
New Jersey (66)
New York (45)
North Carolina (88)
Northern California (334)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (46)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (338)
Tennessee (2)
Texas (67)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (47)
Wisconsin (6)
38,080 Results for "xenetic biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
March 19, 2025
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses
March 13, 2025
·
7 min read
Press Releases
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma
March 27, 2025
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting
February 27, 2025
·
1 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
Business
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Xenetic Biosciences, Inc. today reported its financial results for the first quarter of 2024 and provided a business update.
May 10, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results
November 13, 2024
·
6 min read
Business
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
Xenetic Biosciences, Inc. today reported its financial results for the year ended December 31, 2023.
March 22, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
December 17, 2024
·
6 min read
Press Releases
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
November 8, 2024
·
6 min read
1 of 3,808
Next
